531592 GENPHARMA

Genpharmasec Share Price

₹3.20 +0.02 (0.63%)

28 Dec, 2024 16:36

SIP TrendupStart SIP in GENPHARMA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 12.68%
  • Over 3 Month + 4.92%
  • Over 6 Month + 58.42%
  • Over 1 Year + 18.96%
SIP Lightning

Smart Investing Starts Here Start SIP with Genpharmasec for Steady Growth!

Invest Now

Genpharmasec Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Genpharmasec Financials

Genpharmasec Technicals

EMA & SMA

Current Price
₹3.20
+ 0.02 (0.63%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹3.33
  • 50 Day
  • ₹3.20
  • 100 Day
  • ₹3.05
  • 200 Day
  • ₹2.92

Resistance and Support

3.18 Pivot Speed
  • R3 3.40
  • R2 3.32
  • R1 3.26
  • S1 3.12
  • S2 3.04
  • S3 2.98

What's your outlook on Genpharmasec?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Genpharmasec has an operating revenue of Rs. 41.63 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 12% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -17% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 20 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genpharmasec Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results
2024-06-27 A.G.M.
2024-05-24 Audited Results
2024-03-27 Others inter alia, to consider : 1. To consider and take on record the resignation of Mr. Ulhas Deosthale from the post of Whole-Time Director; issue of equity shares of Re. 1/- in the ratio of 1:1 @ premium of Re. 0.75/-.

Genpharmasec F&O

Genpharmasec Shareholding Pattern

29.98%
0%
59.55%
0%

About Genpharmasec

  • NSE Symbol
  • GENPHARMA
  • BSE Symbol
  • 531592
  • ISIN
  • INE861N01036

Similar Stocks to Genpharmasec

Genpharmasec FAQs

Genpharmasec share price is ₹3 As on 28 December, 2024 | 16:22

The Market Cap of Genpharmasec is ₹177.2 Cr As on 28 December, 2024 | 16:22

The P/E ratio of Genpharmasec is 110.8 As on 28 December, 2024 | 16:22

The PB ratio of Genpharmasec is 2.8 As on 28 December, 2024 | 16:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23